CABP

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 561811

CAS#: 27442-42-8

Description: CABP is a transition state analog of ribulose-1,5-bisphosphate carboxylase/oxygenase (rubisco).


Price and Availability

Size
Price

Size
Price

Size
Price

CABP is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 561811
Name: CABP
CAS#: 27442-42-8
Chemical Formula: C6H14O13P2
Exact Mass: 355.991
Molecular Weight: 356.11
Elemental Analysis: C, 20.24; H, 3.96; O, 58.40; P, 17.40


Synonym: CABP; 2-CABP; 2 CABP; 2CABP;

IUPAC/Chemical Name: (2R,3R,4R)-2,3,4-trihydroxy-5-phosphonooxy-2-(phosphonooxymethyl)pentanoic acid

InChi Key: ITHCSGCUQDMYAI-ZMIZWQJLSA-N

InChi Code: InChI=1S/C6H14O13P2/c7-3(1-18-20(12,13)14)4(8)6(11,5(9)10)2-19-21(15,16)17/h3-4,7-8,11H,1-2H2,(H,9,10)(H2,12,13,14)(H2,15,16,17)/t3-,4-,6-/m1/s1

SMILES Code: O=C(O)[C@](COP(O)(O)=O)(O)[C@H](O)[C@H](O)COP(O)(O)=O


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Donald BJ, Surani S, Deol HS, Mbadugha UJ, Udeani G. Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy. Drug Des Devel Ther. 2017 Dec 13;11:3559-3566. doi: 10.2147/DDDT.S119545. eCollection 2017. Review. PubMed PMID: 29263651; PubMed Central PMCID: PMC5732564.

2: Li Q, Zhao X, Wang S, Zhou Z. Letrozole induced low estrogen levels affected the expressions of duodenal and renal calcium-processing gene in laying hens. Gen Comp Endocrinol. 2018 Jan 1;255:49-55. doi: 10.1016/j.ygcen.2017.10.005. Epub 2017 Oct 14. Review. PubMed PMID: 29037849.

3: Buege MJ, Brown JE, Aitken SL. Solithromycin: A novel ketolide antibiotic. Am J Health Syst Pharm. 2017 Jun 15;74(12):875-887. doi: 10.2146/ajhp160934. Epub 2017 Apr 21. Review. PubMed PMID: 28432048.

4: Yim J, Molloy LM, Newland JG. Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application. Infect Dis Ther. 2017 Mar;6(1):57-67. doi: 10.1007/s40121-016-0144-8. Epub 2016 Dec 30. Review. PubMed PMID: 28039666; PubMed Central PMCID: PMC5336419.

5: Zhanel GG, Hartel E, Adam H, Zelenitsky S, Zhanel MA, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty AJ, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia. Drugs. 2016 Dec;76(18):1737-1757. Review. PubMed PMID: 27909995.

6: Fernandes P, Martens E. Antibiotics in late clinical development. Biochem Pharmacol. 2017 Jun 1;133:152-163. doi: 10.1016/j.bcp.2016.09.025. Epub 2016 Sep 26. Review. PubMed PMID: 27687641.

7: Hadzic M, Jack A, Wahle P. Ionotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex. J Comp Neurol. 2017 Mar 1;525(4):976-1033. doi: 10.1002/cne.24103. Epub 2016 Sep 27. Review. PubMed PMID: 27560295.

8: Thomas CM, Timson DJ. A mysterious family of calcium-binding proteins from parasitic worms. Biochem Soc Trans. 2016 Aug 15;44(4):1005-10. doi: 10.1042/BST20150270. Review. PubMed PMID: 27528745.

9: Tanaka SK, Steenbergen J, Villano S. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic. Bioorg Med Chem. 2016 Dec 15;24(24):6409-6419. doi: 10.1016/j.bmc.2016.07.029. Epub 2016 Jul 18. Review. PubMed PMID: 27469981.

10: Jones TM, Johnson SW, DiMondi VP, Wilson DT. Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Infect Drug Resist. 2016 Jun 7;9:119-28. doi: 10.2147/IDR.S105620. eCollection 2016. Review. PubMed PMID: 27354817; PubMed Central PMCID: PMC4908938.

11: Gorkhali R, Huang K, Kirberger M, Yang JJ. Defining potential roles of Pb(2+) in neurotoxicity from a calciomics approach. Metallomics. 2016 Jun 1;8(6):563-78. doi: 10.1039/c6mt00038j. Review. PubMed PMID: 27108875; PubMed Central PMCID: PMC4979543.

12: Van Bambeke F, Tulkens PM. The role of solithromycin in the management of bacterial community-acquired pneumonia. Expert Rev Anti Infect Ther. 2016;14(3):311-24. doi: 10.1586/14787210.2016.1138857. Epub 2016 Feb 5. Review. PubMed PMID: 26848612.

13: Lehmann H, Pabst JY. [Phytovigilance: A medical requirement and a legal obligation]. Ann Pharm Fr. 2016 Jan;74(1):49-60. doi: 10.1016/j.pharma.2015.06.004. Epub 2015 Jul 22. Review. French. PubMed PMID: 26210820.

14: Yoneda T, Hiasa M, Nagata Y, Okui T, White FA. Acidic microenvironment and bone pain in cancer-colonized bone. Bonekey Rep. 2015 May 6;4:690. doi: 10.1038/bonekey.2015.58. eCollection 2015. Review. PubMed PMID: 25987988; PubMed Central PMCID: PMC4422089.

15: Yoneda T, Hiasa M, Nagata Y, Okui T, White F. Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain. Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2677-84. doi: 10.1016/j.bbamem.2015.02.004. Epub 2015 Feb 14. Review. PubMed PMID: 25687976; PubMed Central PMCID: PMC5356024.

16: Stryjewski ME, Jones RN, Corey GR. Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA. Diagn Microbiol Infect Dis. 2015 Mar;81(3):183-8. doi: 10.1016/j.diagmicrobio.2014.11.016. Epub 2014 Dec 3. Review. PubMed PMID: 25583130.

17: Merker A, Danziger LH, Rodvold KA, Glowacki RC. Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil. Expert Opin Drug Metab Toxicol. 2014 Dec;10(12):1741-50. doi: 10.1517/17425255.2014.972932. Epub 2014 Oct 27. Review. PubMed PMID: 25347329.

18: Carreno JJ, Lodise TP. Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE. Infect Dis Ther. 2014 Dec;3(2):123-32. doi: 10.1007/s40121-014-0036-8. Epub 2014 Sep 6. Review. PubMed PMID: 25193094; PubMed Central PMCID: PMC4269637.

19: Amin AN, Cerceo EA, Deitelzweig SB, Pile JC, Rosenberg DJ, Sherman BM. The hospitalist perspective on treatment of community-acquired bacterial pneumonia. Postgrad Med. 2014 Mar;126(2):18-29. doi: 10.3810/pgm.2014.03.2737. Review. PubMed PMID: 24685965.

20: Srivastava SS, Mishra A, Krishnan B, Sharma Y. Ca2+-binding motif of βγ-crystallins. J Biol Chem. 2014 Apr 18;289(16):10958-66. doi: 10.1074/jbc.O113.539569. Epub 2014 Feb 24. Review. PubMed PMID: 24567326; PubMed Central PMCID: PMC4036236.